Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Nov 15, 2021; 13(11): 1709-1724
Published online Nov 15, 2021. doi: 10.4251/wjgo.v13.i11.1709
Published online Nov 15, 2021. doi: 10.4251/wjgo.v13.i11.1709
Figure 6 CBX8 promotes the growth and proliferation of pancreatic cancer cells through IRS1 in vivo.
A: Viability of BXPC-3 and PANC1 cells after transfection with CBX8 knockdown and/or IRS1 plasmid; B: Colony formation assay was performed to evaluate the effect of CBX8 on PC cell proliferation; C: Images of tumors harvested from each group; D: Weight of tumors in each group; E: Tumor growth curve drawn based on the tumor size measured each week; F: Representative images of immunohistochemistry staining for Ki67 in xenograft tumors; G: Schematic model illustrating that HIF-1a-meditated CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis. aP < 0.05, bP < 0.01.
- Citation: Teng BW, Zhang KD, Yang YH, Guo ZY, Chen WW, Qiu ZJ. Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis. World J Gastrointest Oncol 2021; 13(11): 1709-1724
- URL: https://www.wjgnet.com/1948-5204/full/v13/i11/1709.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i11.1709